Implantation of an arrhythmia management system for ventricular and supraventricular tachyarrhythmias

Influence of obstructive sleep apnea on heart rate turbulence.

Basic research in cardiology·2005

[Atrial fibrillation -- interventional therapy with respect to age].

Deutsche medizinische Wochenschrift (1946)·2005

Atrial fibrillation: profit from cardiac pacing?

Zeitschrift fur Kardiologie·2005

[Progressive upper lobe consolidation in a 73-year old healthy woman].

Der Internist·2005

[Interventional catheter closure of persistent foramen ovale (PFO) in a patient with paradoxical embolism and Brugada's syndrome].

Deutsche medizinische Wochenschrift (1946)·2004

Mayer-von Rokitansky-Küster-Hauser syndrome in association with a hitherto undescribed variant of the Holt-Oram syndrome with an aorto-pulmonary window.

Human reproduction (Oxford, England)·2004

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Adaptive Arc-Voltage Control for Narrow-Gap Pulsed TIG Welding Based on Feedback Reconstruction and Effective-Error Identification.

Sensors (Basel, Switzerland)·2026

Design of a Textile-Integrated Piezoelectric Braided Cord Sensor for Sleep Apnea Monitoring.

Micromachines·2026

Electrochemical Stability of Electrodeposited PEDOT:PSS Neural Stimulation Electrodes.

Micromachines·2026

Design and Development of Microneedle Electrodes for Automated External Defibrillators.

Micromachines·2026

Programmable Axial-Radial Multichannel Nickel Microtubes Fabricated by Core-Filament Jet Electrodeposition.

Micromachines·2026

Establishing a List of Parameters and Their Empirical Calibration via Simulations of Some Experimental Graphene-Based Transistors.

Micromachines·2026

Related Experiment Videos

Implantation of an arrhythmia management system for ventricular and supraventricular tachyarrhythmias

Related Concept Videos

Influence of obstructive sleep apnea on heart rate turbulence.

[Atrial fibrillation -- interventional therapy with respect to age].

Atrial fibrillation: profit from cardiac pacing?

[Progressive upper lobe consolidation in a 73-year old healthy woman].

[Interventional catheter closure of persistent foramen ovale (PFO) in a patient with paradoxical embolism and Brugada's syndrome].

Mayer-von Rokitansky-Küster-Hauser syndrome in association with a hitherto undescribed variant of the Holt-Oram syndrome with an aorto-pulmonary window.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Adaptive Arc-Voltage Control for Narrow-Gap Pulsed TIG Welding Based on Feedback Reconstruction and Effective-Error Identification.

Design of a Textile-Integrated Piezoelectric Braided Cord Sensor for Sleep Apnea Monitoring.

Electrochemical Stability of Electrodeposited PEDOT:PSS Neural Stimulation Electrodes.

Design and Development of Microneedle Electrodes for Automated External Defibrillators.

Programmable Axial-Radial Multichannel Nickel Microtubes Fabricated by Core-Filament Jet Electrodeposition.

Establishing a List of Parameters and Their Empirical Calibration via Simulations of Some Experimental Graphene-Based Transistors.

Related Experiment Videos

Implantation of an arrhythmia management system for ventricular and supraventricular tachyarrhythmias

Related Concept Videos

Related Articles